Related Experiment Video
Updated: Jul 23, 2026

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Real-world uptake of an innovative pupil expander device for cataract surgery: Implementation lessons learnt
1Nayan Eye Centre & Med Invent Devices Pvt. Ltd., Kolkata, India.
The Indian Journal of Medical Research
|October 3, 2024
Summary
Cataract surgery complications arise from small pupils that do not dilate. The B-HEX Pupil Expander offers a safe, effective mechanical solution, overcoming limitations of previous devices.
Area of Science:
- Ophthalmology
- Surgical Devices
Background:
- Small, non-dilating pupils during cataract surgery lead to vision-threatening complications.
- Prevalence is increasing due to factors like benign prostatic hyperplasia (BPH), hypertension, diabetes, and new presbyopia treatments.
- Existing pharmacological and mechanical methods have limitations, including difficulty of use and safety concerns.
Purpose of the Study:
- To introduce and evaluate the B-HEX Pupil Expander, a novel mechanical device designed to address the challenges of non-dilating pupils in cataract surgery.
- To highlight the design features and advantages of the B-HEX Pupil Expander over existing solutions.
Main Methods:
- The B-HEX Pupil Expander features a patented single-plane, hexagonal design with notches and flanges.
- It is US FDA registered and manufactured for ease of use, consistency, safety, and affordability.
- Evaluation of its adoption, market performance, and barriers to global distribution.
Main Results:
- The B-HEX design overcomes limitations of previous devices, offering a safe, effective, and easy-to-use solution for non-dilating pupils.
- It has achieved market leadership in India, with growing peer acceptance and endorsements.
- Despite advantages, regulatory hurdles and resource constraints impede global availability.
Conclusions:
- The B-HEX Pupil Expander represents a significant advancement in managing non-dilating pupils during cataract surgery.
- Addressing implementation barriers is crucial for wider patient access to this superior and affordable option.
- Strategic partnerships are essential to scale global reach and establish market leadership.

